Targeting pathogen metabolism without collateral damage to the host
暂无分享,去创建一个
Jacky L. Snoep | Hans V. Westerhoff | Barbara M. Bakker | Hermann-Georg Holzhütter | Albert Gerding | Keith R. Matthews | Manon Buist-Homan | K. Faber | H. Westerhoff | H. Holzhütter | J. Snoep | A. Gerding | A. Dolga | K. Matthews | J. Haanstra | F. du Toit | Amalia M. Dolga | Jurgen R. Haanstra | Freek J. H. Sorgdrager | François du Toit | Klaas Nico Faber | Balázs Szöör | F. Sorgdrager | M. Buist-Homan | B. Szöör
[1] Robert A Copeland,et al. Evaluation of enzyme inhibitors in drug discovery. A guide for medicinal chemists and pharmacologists. , 2005, Methods of biochemical analysis.
[2] D. Niekerk,et al. Targeting glycolysis in the malaria parasite Plasmodium falciparum , 2016, The FEBS journal.
[3] Wouter W van Solinge,et al. The energy-less red blood cell is lost: erythrocyte enzyme abnormalities of glycolysis. , 2005, Blood.
[4] Peter J. Butterworth,et al. Fundamentals of enzyme kinetics (3rd edn) A. Cornish-Bowden. Portland Press Ltd, London, 422 + xvi pp., ISBN 1 85578 158 1 (2000) , 2005 .
[5] M. Barrett,et al. Human African trypanosomiasis: pharmacological re‐engagement with a neglected disease , 2007, British journal of pharmacology.
[6] D. Fell. Understanding the Control of Metabolism , 1996 .
[7] P. Low,et al. Role of band 3 in regulating metabolic flux of red blood cells , 2009, Proceedings of the National Academy of Sciences.
[8] P W Kuchel,et al. Model of 2,3-bisphosphoglycerate metabolism in the human erythrocyte based on detailed enzyme kinetic equations: computer simulation and metabolic control analysis. , 1999, The Biochemical journal.
[9] I. Kola,et al. Can the pharmaceutical industry reduce attrition rates? , 2004, Nature Reviews Drug Discovery.
[10] M. Barrett,et al. Kinetoplastid glucose transporters. , 1997, The Biochemical journal.
[11] David R. Gilbert,et al. Handling Uncertainty in Dynamic Models: The Pentose Phosphate Pathway in Trypanosoma brucei , 2013, PLoS Comput. Biol..
[12] B. Vanhollebeke,et al. The trypanolytic factor of human serum: many ways to enter the parasite, a single way to kill , 2010, Molecular microbiology.
[13] I. Kola,et al. The State of Innovation in Drug Development , 2008, Clinical pharmacology and therapeutics.
[14] Barbara M. Bakker,et al. Experimental and in Silico Analyses of Glycolytic Flux Control in Bloodstream Form Trypanosoma brucei* , 2005, Journal of Biological Chemistry.
[15] W. J. Herbert,et al. Trypanosoma brucei: a rapid "matching" method for estimating the host's parasitemia. , 1976, Experimental parasitology.
[16] A. Cornish-Bowden. Fundamentals of Enzyme Kinetics , 1979 .
[17] P. Jansen,et al. Superoxide anions and hydrogen peroxide induce hepatocyte death by different mechanisms: involvement of JNK and ERK MAP kinases. , 2006, Journal of hepatology.
[18] Reinhard Hickel,et al. Real-time xCELLigence impedance analysis of the cytotoxicity of dental composite components on human gingival fibroblasts. , 2010, Dental Materials.
[19] N. Lang-Unnasch,et al. Metabolic changes of the malaria parasite during the transition from the human to the mosquito host. , 1998, Annual review of microbiology.
[20] Barbara M. Bakker,et al. A domino effect in drug action: from metabolic assault towards parasite differentiation , 2011, Molecular microbiology.
[21] Mudita Singhal,et al. COPASI - a COmplex PAthway SImulator , 2006, Bioinform..
[22] J. Vera,et al. Human erythrocytes express GLUT5 and transport fructose. , 1997, Blood.
[23] P. Kuchel,et al. Glucose transport in human erythrocytes measured using 13C NMR spin transfer , 1987, FEBS letters.
[24] P. Wei,et al. In vitro and in vivo study of phloretin‐induced apoptosis in human liver cancer cells involving inhibition of type II glucose transporter , 2009, International journal of cancer.
[25] Richard A Norman,et al. Structural approaches to obtain kinase selectivity. , 2012, Trends in pharmacological sciences.
[26] Barbara M. Bakker,et al. What Controls Glycolysis in Bloodstream Form Trypanosoma brucei?* , 1999, The Journal of Biological Chemistry.
[27] P. Simarro,et al. Epidemiology of human African trypanosomiasis , 2014, Clinical epidemiology.
[28] Chao Xu,et al. Crystal structure of the human glucose transporter GLUT1 , 2014, Nature.
[29] Ying Wei,et al. Glut1 deficiency syndrome and erythrocyte glucose uptake assay , 2011, Annals of neurology.
[30] S. Krishna,et al. Validation of the hexose transporter of Plasmodium falciparum as a novel drug target , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[31] D. Oesterhelt,et al. Methoden der enzymatischen Analyse. Herausgeg. von H. U. Bergmeyer. Verlag Chemie GmbH, Weinheim/Bergstr. 1970. 2. Aufl., LXIX, 2220 S., zahlr. Abb., geb. DM 285.— , 1971 .
[32] R. M. Owen,et al. An analysis of the attrition of drug candidates from four major pharmaceutical companies , 2015, Nature Reviews Drug Discovery.
[33] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[34] K. van Dam,et al. Phloretin - an uncoupler and an inhibitor of mitochondrial oxidative phosphorylation. , 1983, Biochimica et biophysica acta.
[35] W. Breuer,et al. Characterization of permeation pathways in the plasma membrane of human erythrocytes infected with early stages of Plasmodium falciparum: Association with parasite development , 1985, Journal of cellular physiology.
[36] C. Culmsee,et al. SK channel activation modulates mitochondrial respiration and attenuates neuronal HT-22 cell damage induced by H2O2 , 2015, Neurochemistry International.
[37] Andreas Seyfang,et al. Specificity of glucose transport in Trypanosoma brucei , 1991 .
[38] K. Matthews,et al. Independent Pathways Can Transduce the Life-Cycle Differentiation Signal in Trypanosoma brucei , 2013, PLoS pathogens.
[39] Barbara M. Bakker,et al. Proliferating bloodstream-form Trypanosoma brucei use a negligible part of consumed glucose for anabolic processes. , 2012, International journal for parasitology.
[40] Eytan Ruppin,et al. Metabolic reconstruction, constraint-based analysis and game theory to probe genome-scale metabolic networks. , 2010, Current opinion in biotechnology.
[41] S. Bulik,et al. Quantifying the Contribution of the Liver to Glucose Homeostasis: A Detailed Kinetic Model of Human Hepatic Glucose Metabolism , 2012, PLoS Comput. Biol..
[42] A. K. Solomon,et al. Interaction between phloretin and the red blood cell membrane , 1976, The Journal of general physiology.
[43] Barbara M. Bakker,et al. Contribution of glucose transport to the control of the glycolytic flux in Trypanosoma brucei. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[44] H. Holzhütter. The principle of flux minimization and its application to estimate stationary fluxes in metabolic networks. , 2004, European journal of biochemistry.
[45] H. Pinkofsky,et al. Structure of cytochalasins and cytochalasin B binding sites in human erythrocyte membranes. , 1980, Biochemistry.
[46] C. Clayton,et al. Vectors for inducible expression of toxic gene products in bloodstream and procyclic Trypanosoma brucei. , 1997, Molecular and biochemical parasitology.
[47] Nicolas Le Novère,et al. BioModels Database: a repository of mathematical models of biological processes. , 2013, Methods in molecular biology.
[48] C. Jung,et al. Cytochalasin B binding sites and glucose transport carrier in human erythrocyte ghosts. , 1977, The Journal of biological chemistry.
[49] M. Sitbon,et al. Erythroid glucose transporters , 2009, Current opinion in hematology.
[50] H. Holzhütter,et al. Use of mathematical models for predicting the metabolic effect of large-scale enzyme activity alterations. Application to enzyme deficiencies of red blood cells. , 1995, European journal of biochemistry.
[51] Isabel M. Vincent,et al. Drug resistance in human African trypanosomiasis. , 2011, Future microbiology.
[52] R. Heinrich,et al. The Regulation of Cellular Systems , 1996, Springer US.
[53] N. Davies,et al. HPLC-UV Analysis of Phloretin in Biological Fluids and Application to Pre-Clinical Pharmacokinetic Studies , 2010 .
[54] R. Eisenthal,et al. The aerobic/anaerobic transition of glucose metabolism in Trypanosoma brucei , 1985, FEBS letters.
[55] P. Michels,et al. Glycosomal targets for anti-trypanosomatid drug discovery. , 2014, Current medicinal chemistry.